avrg: SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
ZNF148
|
ENSG00000163848.14 | zinc finger protein 148 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
ZNF148 | hg19_v2_chr3_-_125094093_125094198 | 0.67 | 1.3e-03 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.9 | 8.7 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
2.4 | 7.3 | GO:0048597 | B cell negative selection(GO:0002352) post-embryonic camera-type eye morphogenesis(GO:0048597) |
2.1 | 29.1 | GO:0036484 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
2.1 | 8.2 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
1.9 | 9.3 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
1.7 | 5.0 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
1.6 | 6.4 | GO:1900138 | negative regulation of phospholipase A2 activity(GO:1900138) |
1.6 | 4.8 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
1.6 | 27.0 | GO:0035878 | nail development(GO:0035878) |
1.5 | 8.9 | GO:0030421 | defecation(GO:0030421) |
1.4 | 4.2 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
1.4 | 8.2 | GO:0072752 | cellular response to rapamycin(GO:0072752) |
1.1 | 6.6 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
1.0 | 7.1 | GO:0060600 | dichotomous subdivision of an epithelial terminal unit(GO:0060600) |
1.0 | 18.1 | GO:0015816 | glycine transport(GO:0015816) |
1.0 | 4.9 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.9 | 2.7 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
0.9 | 6.0 | GO:1902164 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
0.9 | 4.3 | GO:1904448 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
0.8 | 3.4 | GO:1904978 | regulation of endosome organization(GO:1904978) |
0.8 | 1.6 | GO:0048627 | myoblast development(GO:0048627) |
0.8 | 2.4 | GO:0050904 | diapedesis(GO:0050904) |
0.8 | 8.6 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.8 | 3.0 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
0.8 | 3.0 | GO:1904499 | glial cell fate determination(GO:0007403) canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation(GO:0061324) regulation of chromatin-mediated maintenance of transcription(GO:1904499) positive regulation of chromatin-mediated maintenance of transcription(GO:1904501) regulation of euchromatin binding(GO:1904793) |
0.7 | 3.0 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
0.7 | 8.1 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.7 | 7.3 | GO:1903764 | regulation of potassium ion export across plasma membrane(GO:1903764) |
0.7 | 7.6 | GO:0031944 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) negative regulation of steroid hormone biosynthetic process(GO:0090032) |
0.7 | 8.2 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.7 | 4.0 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.7 | 4.6 | GO:0051012 | microtubule sliding(GO:0051012) |
0.6 | 1.9 | GO:0033341 | regulation of collagen binding(GO:0033341) |
0.6 | 12.5 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.6 | 8.7 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.6 | 1.9 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.6 | 4.3 | GO:0006344 | optic cup formation involved in camera-type eye development(GO:0003408) maintenance of chromatin silencing(GO:0006344) |
0.6 | 4.2 | GO:0045229 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
0.6 | 17.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.6 | 1.7 | GO:0001300 | chronological cell aging(GO:0001300) |
0.6 | 5.7 | GO:2000467 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.6 | 2.2 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.6 | 1.1 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) |
0.5 | 4.4 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.5 | 22.9 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.5 | 3.0 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
0.5 | 6.0 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
0.5 | 2.8 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.5 | 1.4 | GO:0003249 | cell proliferation involved in heart valve morphogenesis(GO:0003249) regulation of cell proliferation involved in heart valve morphogenesis(GO:0003250) |
0.5 | 2.7 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.5 | 3.2 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.5 | 3.2 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.4 | 1.3 | GO:1904247 | positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
0.4 | 1.3 | GO:0033488 | cholesterol biosynthetic process via 24,25-dihydrolanosterol(GO:0033488) |
0.4 | 3.9 | GO:0072553 | terminal button organization(GO:0072553) |
0.4 | 1.3 | GO:0021648 | vestibulocochlear nerve morphogenesis(GO:0021648) vestibulocochlear nerve formation(GO:0021650) |
0.4 | 3.0 | GO:0051414 | response to cortisol(GO:0051414) |
0.4 | 3.4 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.4 | 5.9 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.4 | 5.4 | GO:0042048 | olfactory behavior(GO:0042048) |
0.4 | 7.6 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.4 | 3.6 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) |
0.4 | 1.2 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.4 | 2.2 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.4 | 4.7 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.3 | 1.7 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.3 | 3.0 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.3 | 1.0 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
0.3 | 5.9 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.3 | 6.4 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.3 | 4.1 | GO:0034201 | response to oleic acid(GO:0034201) |
0.3 | 5.1 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.3 | 1.5 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
0.3 | 4.8 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.3 | 1.5 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.3 | 1.7 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.3 | 3.4 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.3 | 1.1 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.3 | 8.1 | GO:0016180 | snRNA processing(GO:0016180) |
0.3 | 3.7 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.3 | 1.6 | GO:0030047 | actin modification(GO:0030047) |
0.3 | 2.1 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.2 | 3.9 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.2 | 2.9 | GO:2000576 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.2 | 2.1 | GO:1905232 | cellular response to L-glutamate(GO:1905232) |
0.2 | 0.9 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.2 | 6.7 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.2 | 1.4 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.2 | 1.5 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
0.2 | 0.4 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.2 | 2.4 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.2 | 2.6 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.2 | 0.8 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.2 | 1.1 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.2 | 2.7 | GO:0009414 | response to water deprivation(GO:0009414) |
0.2 | 1.9 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.2 | 0.6 | GO:0043634 | polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
0.2 | 8.3 | GO:0000717 | nucleotide-excision repair, DNA duplex unwinding(GO:0000717) |
0.2 | 4.6 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.2 | 6.1 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
0.2 | 7.5 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.2 | 1.4 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.2 | 1.4 | GO:0045921 | positive regulation of exocytosis(GO:0045921) |
0.2 | 1.7 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
0.2 | 3.4 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.2 | 6.2 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.2 | 0.5 | GO:0035284 | rhombomere 5 development(GO:0021571) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.2 | 1.6 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 1.5 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.1 | 2.1 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
0.1 | 0.9 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.1 | 1.8 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 1.7 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.1 | 2.0 | GO:0072104 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
0.1 | 0.8 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.1 | 1.1 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.1 | 7.0 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.1 | 0.9 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
0.1 | 1.8 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
0.1 | 1.0 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.1 | 1.5 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 1.3 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.1 | 2.6 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.1 | 0.6 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.1 | 1.3 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.1 | 2.4 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.1 | 0.3 | GO:0072616 | interleukin-18 secretion(GO:0072616) |
0.1 | 1.2 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.1 | 0.3 | GO:0097359 | UDP-glucosylation(GO:0097359) |
0.1 | 0.4 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 2.5 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 4.9 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
0.1 | 0.4 | GO:0035425 | autocrine signaling(GO:0035425) |
0.1 | 6.7 | GO:0008038 | neuron recognition(GO:0008038) |
0.1 | 1.4 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 4.4 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.1 | 1.6 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 3.3 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 1.6 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 1.0 | GO:0034378 | chylomicron assembly(GO:0034378) |
0.1 | 2.4 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.9 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.9 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.1 | 5.3 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.1 | 1.5 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.1 | 1.7 | GO:0036065 | fucosylation(GO:0036065) |
0.1 | 4.5 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.1 | 0.2 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.1 | 2.4 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.1 | 0.6 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.1 | 0.9 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.1 | 0.6 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.1 | 0.3 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.1 | 4.3 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 2.1 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
0.1 | 0.6 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.1 | 0.8 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.1 | 0.8 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.1 | 0.6 | GO:0060313 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
0.1 | 0.6 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.1 | 0.9 | GO:0007512 | adult heart development(GO:0007512) |
0.1 | 0.8 | GO:0034465 | response to carbon monoxide(GO:0034465) |
0.1 | 1.1 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 0.2 | GO:0010157 | response to chlorate(GO:0010157) |
0.1 | 1.9 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.1 | 0.4 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.1 | 1.4 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.1 | 0.2 | GO:0048104 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
0.1 | 1.1 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.1 | 0.7 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.1 | 0.5 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 0.5 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.1 | 0.8 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.1 | 0.9 | GO:0014029 | neural crest formation(GO:0014029) |
0.1 | 1.3 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.1 | 1.7 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.4 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
0.0 | 0.1 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.0 | 0.3 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
0.0 | 0.1 | GO:0050823 | peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) |
0.0 | 0.2 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
0.0 | 0.6 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.0 | 1.2 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.0 | 6.5 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.4 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.0 | 1.1 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.0 | 0.1 | GO:1905203 | regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904596) negative regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904597) regulation of advanced glycation end-product receptor activity(GO:1904603) negative regulation of advanced glycation end-product receptor activity(GO:1904604) regulation of connective tissue replacement(GO:1905203) negative regulation of connective tissue replacement(GO:1905204) |
0.0 | 1.2 | GO:0044804 | nucleophagy(GO:0044804) |
0.0 | 0.5 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.0 | 0.5 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.0 | 3.4 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.0 | 0.3 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
0.0 | 2.7 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.0 | 1.3 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
0.0 | 2.1 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.0 | 0.9 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.0 | 1.2 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.1 | GO:0015870 | acetylcholine transport(GO:0015870) |
0.0 | 1.4 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.5 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
0.0 | 0.1 | GO:1902725 | negative regulation of satellite cell differentiation(GO:1902725) |
0.0 | 1.0 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.0 | 0.8 | GO:0033622 | integrin activation(GO:0033622) |
0.0 | 0.5 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.0 | 0.2 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.0 | 1.9 | GO:0097581 | lamellipodium organization(GO:0097581) |
0.0 | 3.4 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.0 | 2.5 | GO:0030888 | regulation of B cell proliferation(GO:0030888) |
0.0 | 2.5 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.0 | 1.2 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.0 | 2.7 | GO:0000045 | autophagosome assembly(GO:0000045) |
0.0 | 1.1 | GO:0001662 | behavioral fear response(GO:0001662) behavioral defense response(GO:0002209) |
0.0 | 0.6 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.0 | 1.2 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.0 | 0.2 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) cerebral cortex GABAergic interneuron development(GO:0021894) interneuron migration(GO:1904936) |
0.0 | 1.0 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.0 | 4.9 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.1 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
0.0 | 0.6 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.0 | 0.5 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.0 | 0.1 | GO:0061056 | sclerotome development(GO:0061056) |
0.0 | 1.8 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.0 | 0.4 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
0.0 | 0.4 | GO:0006363 | transcription elongation from RNA polymerase I promoter(GO:0006362) termination of RNA polymerase I transcription(GO:0006363) |
0.0 | 0.6 | GO:0040029 | regulation of gene expression, epigenetic(GO:0040029) |
0.0 | 0.3 | GO:0034776 | response to histamine(GO:0034776) cellular response to histamine(GO:0071420) |
0.0 | 0.4 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 1.6 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 4.8 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.0 | 0.9 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.0 | 0.0 | GO:0045402 | interleukin-4 biosynthetic process(GO:0042097) positive regulation of interleukin-10 biosynthetic process(GO:0045082) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.0 | 2.5 | GO:0043543 | protein acylation(GO:0043543) |
0.0 | 0.2 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 1.1 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.0 | 1.5 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.0 | 1.2 | GO:0007004 | telomere maintenance via telomerase(GO:0007004) |
0.0 | 1.2 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.0 | 1.3 | GO:0016575 | histone deacetylation(GO:0016575) |
0.0 | 0.1 | GO:0032228 | regulation of synaptic transmission, GABAergic(GO:0032228) synaptic transmission, GABAergic(GO:0051932) |
0.0 | 1.2 | GO:0031295 | T cell costimulation(GO:0031295) |
0.0 | 0.7 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.7 | 27.0 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
2.6 | 10.6 | GO:0005607 | laminin-2 complex(GO:0005607) |
1.1 | 5.7 | GO:0071942 | XPC complex(GO:0071942) |
0.9 | 4.3 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
0.6 | 6.7 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.5 | 8.2 | GO:0001520 | outer dense fiber(GO:0001520) |
0.5 | 7.6 | GO:0042587 | glycogen granule(GO:0042587) |
0.5 | 7.3 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.5 | 8.2 | GO:0031931 | TORC1 complex(GO:0031931) |
0.5 | 3.0 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
0.5 | 2.5 | GO:0034753 | nuclear aryl hydrocarbon receptor complex(GO:0034753) |
0.5 | 2.4 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
0.5 | 7.4 | GO:0032039 | integrator complex(GO:0032039) |
0.5 | 7.3 | GO:0097025 | lateral loop(GO:0043219) MPP7-DLG1-LIN7 complex(GO:0097025) |
0.4 | 1.3 | GO:0016600 | flotillin complex(GO:0016600) |
0.4 | 4.1 | GO:0016589 | NURF complex(GO:0016589) |
0.4 | 3.0 | GO:0070369 | Scrib-APC-beta-catenin complex(GO:0034750) beta-catenin-TCF7L2 complex(GO:0070369) |
0.4 | 1.8 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
0.3 | 8.2 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.3 | 7.6 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.3 | 1.4 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.3 | 1.5 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.2 | 1.0 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.2 | 2.6 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.2 | 3.6 | GO:0032426 | stereocilium tip(GO:0032426) |
0.2 | 6.0 | GO:0005922 | connexon complex(GO:0005922) |
0.2 | 6.0 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.2 | 7.1 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.2 | 2.2 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.2 | 6.1 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 2.8 | GO:0005921 | gap junction(GO:0005921) |
0.2 | 0.5 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
0.2 | 0.6 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.2 | 1.2 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.1 | 1.5 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.1 | 0.6 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.1 | 13.3 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 1.5 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.1 | 5.6 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 10.1 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 1.5 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 3.8 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 3.5 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 1.5 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 4.8 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.1 | 1.2 | GO:0008091 | spectrin(GO:0008091) |
0.1 | 15.2 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.1 | 8.9 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.1 | 1.7 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.8 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 1.9 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 2.2 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 4.9 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 1.3 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 2.8 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.1 | 2.9 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 0.4 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
0.1 | 9.2 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 1.5 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 0.5 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.1 | 3.0 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 4.8 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 0.4 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.1 | 2.7 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 0.6 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 0.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 4.6 | GO:0002102 | podosome(GO:0002102) |
0.1 | 1.0 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 8.7 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 1.5 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.1 | 2.7 | GO:0030118 | clathrin coat(GO:0030118) |
0.1 | 2.2 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.1 | 1.1 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 0.6 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 0.9 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 6.7 | GO:0070469 | respiratory chain(GO:0070469) |
0.1 | 1.4 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 2.7 | GO:0043034 | costamere(GO:0043034) |
0.0 | 5.8 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.0 | 0.4 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 0.8 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.0 | 2.5 | GO:0035861 | site of double-strand break(GO:0035861) |
0.0 | 0.2 | GO:0060187 | cell pole(GO:0060187) |
0.0 | 1.1 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 0.2 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.0 | 3.1 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 1.0 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.0 | 5.6 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 5.1 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.7 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.0 | 0.4 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.6 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.3 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.7 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 0.1 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.0 | 4.1 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.7 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 1.1 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 4.4 | GO:0032432 | actin filament bundle(GO:0032432) |
0.0 | 1.2 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 0.2 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.0 | 0.3 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.0 | 0.5 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.0 | 2.0 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.4 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.0 | 0.8 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.9 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.2 | GO:0000801 | central element(GO:0000801) |
0.0 | 3.1 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.0 | 0.4 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.2 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.0 | 2.2 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.0 | 3.8 | GO:0031902 | late endosome membrane(GO:0031902) |
0.0 | 4.3 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 0.1 | GO:0042825 | TAP complex(GO:0042825) |
0.0 | 1.9 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 1.3 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 5.0 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 6.6 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.0 | 1.2 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 25.0 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.0 | 1.1 | GO:0005795 | Golgi stack(GO:0005795) |
0.0 | 0.9 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.0 | 3.2 | GO:0000785 | chromatin(GO:0000785) |
0.0 | 5.6 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 0.9 | GO:0030529 | intracellular ribonucleoprotein complex(GO:0030529) ribonucleoprotein complex(GO:1990904) |
0.0 | 0.1 | GO:0035102 | PRC1 complex(GO:0035102) |
0.0 | 0.8 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 2.2 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.1 | GO:0042641 | actomyosin(GO:0042641) |
0.0 | 0.9 | GO:0005741 | mitochondrial outer membrane(GO:0005741) organelle outer membrane(GO:0031968) |
0.0 | 1.4 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 11.3 | GO:0005730 | nucleolus(GO:0005730) |
0.0 | 0.7 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.3 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 27.0 | GO:0038132 | neuregulin binding(GO:0038132) |
1.5 | 7.6 | GO:0050115 | myosin-light-chain-phosphatase activity(GO:0050115) |
1.4 | 4.3 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
1.3 | 6.7 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
1.2 | 5.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
1.2 | 18.1 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
1.2 | 27.6 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.9 | 2.7 | GO:0008841 | tetrahydrofolylpolyglutamate synthase activity(GO:0004326) dihydrofolate synthase activity(GO:0008841) |
0.9 | 4.3 | GO:0003867 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
0.8 | 3.4 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) ethanolaminephosphotransferase activity(GO:0004307) |
0.7 | 3.0 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.7 | 5.0 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.7 | 4.2 | GO:0017153 | citrate transmembrane transporter activity(GO:0015137) succinate transmembrane transporter activity(GO:0015141) tricarboxylic acid transmembrane transporter activity(GO:0015142) sodium:dicarboxylate symporter activity(GO:0017153) |
0.7 | 2.1 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.6 | 14.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.6 | 2.5 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
0.6 | 1.8 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.6 | 3.4 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.6 | 7.3 | GO:0097016 | L27 domain binding(GO:0097016) |
0.6 | 2.2 | GO:0098808 | mRNA cap binding(GO:0098808) |
0.5 | 3.9 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.5 | 9.4 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.4 | 1.3 | GO:0008398 | sterol 14-demethylase activity(GO:0008398) |
0.4 | 7.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.4 | 5.9 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.4 | 5.5 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.4 | 1.2 | GO:0004108 | citrate (Si)-synthase activity(GO:0004108) citrate synthase activity(GO:0036440) |
0.4 | 7.6 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.4 | 8.2 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.4 | 2.2 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.4 | 3.0 | GO:0030172 | troponin C binding(GO:0030172) |
0.4 | 2.5 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.3 | 5.2 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.3 | 4.5 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.3 | 1.7 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
0.3 | 6.4 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
0.3 | 8.7 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.3 | 5.0 | GO:0045159 | myosin II binding(GO:0045159) |
0.3 | 7.3 | GO:0051400 | BH domain binding(GO:0051400) |
0.3 | 1.3 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.3 | 1.8 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.3 | 8.6 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
0.3 | 2.4 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.3 | 20.2 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.2 | 0.7 | GO:1990254 | keratin filament binding(GO:1990254) |
0.2 | 9.0 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 1.7 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.2 | 2.4 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.2 | 10.6 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.2 | 1.5 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
0.2 | 1.9 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.2 | 2.9 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.2 | 1.8 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.2 | 1.2 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.2 | 4.8 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 2.1 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.2 | 1.5 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.2 | 0.8 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
0.2 | 1.1 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
0.2 | 0.8 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.1 | 4.1 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.1 | 7.5 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 0.6 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.1 | 4.8 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.1 | 7.9 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.1 | 1.5 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.1 | 4.3 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 2.8 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 1.7 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 0.4 | GO:0051538 | iron-responsive element binding(GO:0030350) 3 iron, 4 sulfur cluster binding(GO:0051538) |
0.1 | 2.2 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 3.3 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 0.6 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 5.7 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 1.3 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 1.0 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.1 | 3.0 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.3 | GO:0003980 | UDP-glucose:glycoprotein glucosyltransferase activity(GO:0003980) |
0.1 | 12.5 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 0.4 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 1.3 | GO:1901612 | phosphatidylglycerol binding(GO:1901611) cardiolipin binding(GO:1901612) |
0.1 | 2.2 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 25.9 | GO:0008083 | growth factor activity(GO:0008083) |
0.1 | 1.8 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 2.6 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 3.7 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 5.5 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.1 | 2.5 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 27.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 0.6 | GO:0043532 | angiostatin binding(GO:0043532) |
0.1 | 12.1 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 9.0 | GO:0004004 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) |
0.1 | 0.8 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.1 | 1.2 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 12.6 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.1 | 2.1 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.1 | 1.1 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 1.8 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 1.6 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 2.4 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 3.1 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 1.7 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.1 | 2.1 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.1 | 1.0 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.1 | 0.8 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.1 | 0.6 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.1 | 1.4 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 0.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.9 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 2.4 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 0.5 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 0.6 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 3.9 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.1 | 1.2 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 1.1 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.1 | 0.6 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.1 | 0.1 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.0 | 0.2 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.0 | 7.4 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 1.1 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.0 | 1.0 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 3.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 1.0 | GO:0031005 | filamin binding(GO:0031005) |
0.0 | 2.9 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.0 | 1.9 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
0.0 | 1.2 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.0 | 1.0 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.3 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.0 | 0.2 | GO:0005119 | smoothened binding(GO:0005119) |
0.0 | 3.6 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 1.7 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.0 | 3.7 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.0 | 2.4 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.0 | 1.4 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.3 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.0 | 8.6 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.4 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.0 | 4.4 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) |
0.0 | 0.1 | GO:0015433 | peptide antigen-transporting ATPase activity(GO:0015433) |
0.0 | 4.5 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 1.4 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.2 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.0 | 1.6 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 3.9 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 1.4 | GO:0001047 | core promoter binding(GO:0001047) |
0.0 | 2.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 2.4 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.1 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.0 | 3.6 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) |
0.0 | 0.9 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.7 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.0 | 1.1 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 8.2 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 0.2 | GO:0030957 | Tat protein binding(GO:0030957) |
0.0 | 2.3 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.0 | 0.4 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 0.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.7 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 1.9 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.0 | 4.1 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.0 | 0.2 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 3.9 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 6.3 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.3 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 0.6 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.1 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.0 | 0.2 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 44.2 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.3 | 7.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 59.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 14.0 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 7.1 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 8.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 1.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 3.6 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.1 | 9.1 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 5.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 3.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 4.0 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 2.6 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 2.4 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 6.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 10.9 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 4.4 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 3.7 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 7.6 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 3.6 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 7.0 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 1.6 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 30.3 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 0.8 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 9.3 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 2.5 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.1 | 2.9 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.8 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 2.5 | PID ATM PATHWAY | ATM pathway |
0.0 | 8.2 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 2.8 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 4.1 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 2.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.8 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.0 | 0.9 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 3.4 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 0.8 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 1.2 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 1.1 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 1.0 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 1.4 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 7.1 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.0 | 2.0 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.5 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.6 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 1.4 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 8.8 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.4 | 5.3 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.3 | 8.3 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.3 | 7.3 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.2 | 6.0 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 6.0 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.2 | 8.3 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.2 | 6.4 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.2 | 9.4 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.2 | 5.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 4.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.2 | 2.0 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.2 | 4.9 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.2 | 9.5 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.2 | 6.4 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.2 | 8.2 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.2 | 10.9 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.2 | 5.0 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 3.0 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 8.3 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 2.6 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 4.2 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 5.7 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 17.1 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 2.6 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 4.9 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 9.3 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 2.4 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 2.5 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 1.5 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 2.1 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 2.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 1.7 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 4.3 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 4.4 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 1.8 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.1 | 1.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 2.1 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.1 | 1.0 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 1.7 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 1.0 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 2.1 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 2.0 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 2.3 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 1.3 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.0 | 1.1 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 2.3 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 1.3 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
0.0 | 0.8 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 2.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 3.0 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 1.2 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 1.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.7 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 2.1 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 1.2 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 3.3 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.4 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.0 | 9.5 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 1.8 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 2.2 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 0.6 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 4.0 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 2.6 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.4 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.7 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 0.8 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.4 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 8.4 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.0 | 1.2 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.6 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.3 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 1.1 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.4 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.9 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 1.9 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.6 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 1.2 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.0 | 0.3 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |